FBIO
Fortress Biotech Inc

8,936
Loading...
Loading...
News
all
press releases
Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates
Fortress Biotech (FBIO) delivered earnings and revenue surprises of -48.39% and +13.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
More News
News Placeholder
Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates
Repare Therapeutics (RPTX) delivered earnings and revenue surprises of +30.36% and -95.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates
Coherus Oncology (CHRS) delivered earnings and revenue surprises of -9.68% and +1.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Why Fast-paced Mover Fortress Biotech (FBIO) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Fortress Biotech (FBIO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks·2mo ago
News Placeholder
Ultragenyx (RARE) Surges 5.1%: Is This an Indication of Further Gains?
Ultragenyx (RARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·2mo ago
News Placeholder
Despite Fast-paced Momentum, Fortress Biotech (FBIO) Is Still a Bargain Stock
Zacks·3mo ago
News Placeholder
Fortress Biotech (FBIO) Is Attractively Priced Despite Fast-paced Momentum
Zacks·4mo ago
News Placeholder
New Strong Sell Stocks for May 16th
Zacks·4mo ago
News Placeholder
Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates
Zacks·4mo ago
News Placeholder
Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates
Zacks·4mo ago

Latest FBIO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.